Age- and Sex-Specific Prevalence of Lower Urinary Tract Symptoms in Pediatric and Young Adults in a Swedish National Cohort
Renstrom-Koskela, L.; Skokic, V.; Kepinska, A.; Scharp, D.; Gustavsson Mahjani, C.; Humphreys, K.; Buxbaum, J. D.; Grice, D. E.; Mahjani, B.; Akre, O.
Show abstract
BackgroundLower Urinary Tract Symptoms (LUTS significantly impact quality of life and are prevalent across life course. Despite their importance, population-based incidence rates for pediatric and young adult populations, including age and sex-specific differences, remain poorly quantified. MethodsWe analyzed data from all live-born children in Sweden between 1995 and 2005, with follow-up through 2018, extracted from the Swedish National Medical Birth Register. We employed three distinct methods to identify LUTS cases: (1) an ICD-10 diagnostic code approach, (2) a broad ICD-medication approach that includes ICD-10 diagnosis or at least one prescription of LUTS-related medications (anticholinergics, Alfa-1-receptor antagonist, or Beta-3 receptor agonists), and (3) a narrow ICD-medication approach that includes an ICD-10 diagnosis or multiple prescriptions over a specified timeframe. We analyzed sex-specific (sex assigned at birth) and age-specific incidence rates per 100,000 person-years in individuals younger than 24. FindingsThe cohort included 982,903 individuals, 0.1% diagnosed with storage and voiding LUTS based on ICD-10 diagnostic code. Under the broad ICD-medication definition, 0.9% had storage LUTS, and 0.2% had voiding LUTS; the narrow ICD-medication definition identified 0.5% with storage LUTS and 0.1% with voiding LUTS. Notably, females were diagnosed at older ages. ConclusionsThis study reveals an underestimation of LUTS prevalence when relying solely on ICD-10 diagnostic codes. Broader diagnostic criteria uncover higher prevalences and demonstrate varied detection rates and ages at diagnosis by sex. These findings underscore the necessity for more inclusive diagnostic approaches in epidemiological research to capture and understand the full scope of LUTS accurately.
Matching journals
The top 15 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK 91%
- Productivity losses and treatment cost of Benign Prostatic Hyperplasia in Ghana. 91%
- Dynamic analysis of the individual patterns of intakes, voids, and bladder sensations reported in bladder diaries collected in the LURN study 90%
Similar papers in this journal
- Myofascial Frequency Syndrome: A novel syndrome of bothersome lower urinary tract symptoms associated with myofascial pelvic floor dysfunction 96%
- Genetic Polymorphisms, Adherence to Mediterranean Diet and Microbiota-Associated Urolithin Metabotypes: A Complex Cocktail to Predict the Obesity in Childhood-Adolescence 90%
- Chronicling menstrual cycle patterns across the reproductive lifespan with real world data 89%
Similar papers in this journal
- Partial rejuvenation of the spermatogonial stem cell niche after gender-affirming hormone therapy in trans women 90%
- Cervicovaginal immune mediators increase when young women begin to have sexual intercourse: a prospective study and meta-analysis 89%
- Clinical benefits and adverse effects of genetically-elevated free testosterone levels: a Mendelian randomization analysis 89%
Similar papers in this journal
- Prescribing patterns for medical treatment of suspected prostatic obstruction: A spatiotemporal statistical analysis of Scottish open access data 92%
- Men and sexual and reproductive healthcare in the Nordic countries: a scoping review 88%
- The patient experience of COVID-19: A qualitative investigation with symptomatic outpatients 88%
Similar papers in this journal
- BMI and BPH correlate with urinary microbiome diversity and lower urinary tract symptoms in men 90%
- The antibody response to SARS-CoV-2 increases over 5 months in patients with anosmia/dysgeusia 87%
- A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.